Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Kalaris Therapeutics (KLRS) Interest & Investment Income (2019 - 2020)

Kalaris Therapeutics (KLRS) has 2 years of Interest & Investment Income data on record, last reported at $595000.0 in Q4 2020.

  • For Q4 2020, Interest & Investment Income fell 10.53% year-over-year to $595000.0; the TTM value through Dec 2020 reached $1.3 million, changed N/A, while the annual FY2024 figure was $5.5 million, 4.33% down from the prior year.
  • Interest & Investment Income reached $595000.0 in Q4 2020 per KLRS's latest filing, up from $112000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $781000.0 in Q3 2019 and bottomed at $112000.0 in Q3 2020.